Complex Mycotoxin Detoxifier Improves Growth and Liver Health in Broiler Chickens
A recent study published in PLOS One explored the effects of a complex mycotoxin detoxifier (CMD) on the growth performance, liver health, inflammation, and redox status of broiler chickens exposed to multiple mycotoxins. The research involved 432 one-day-old male Ross 308 broiler chicks, which were divided into three dietary treatment groups for a duration of 37 days. The treatments included a control diet free from mycotoxins, a negative control diet contaminated with various mycotoxins, and a diet supplemented with CMD. The mycotoxins tested included aflatoxins, fumonisins, deoxynivalenol, and zearalenone. The study found that the negative control group exhibited higher feed intake but poorer feed efficiency during the initial days of the trial compared to the CMD-supplemented group. Notably, CMD supplementation restored Newcastle disease antibody titers and increased interleukin-10 concentrations, indicating an improvement in immune response. Furthermore, CMD significantly reduced liver inflammation and macroscopic fatty liver scores compared to the negative control group. The research highlights the detrimental effects of mycotoxin exposure on broiler health and the potential of CMD to mitigate these impacts, emphasizing its importance in poultry nutrition and food safety. The findings are particularly relevant given the increasing prevalence of mycotoxin contamination in animal feed, which poses risks to animal health and productivity. This study underscores the need for effective strategies to combat mycotoxin-related challenges in the poultry industry, ensuring the safety and quality of poultry products for consumers. The research was conducted by a team from various institutions, including Kasetsart University and Innovad Group, and was funded by Innovad (Thailand) Company Limited. The study adhered to strict animal welfare guidelines and safety protocols throughout its execution.




